Multidrug-resistant tuberculosis
#1PRI RANKED
Most Cited Paper
in Tuberculosis Research and Epidemiology
18 Months Post-Publication
Class of 2026
“Multidrug-resistant tuberculosis”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
Multidrug-resistant tuberculosis · Multidrug-resistant tuberculosis · rifampicin resistance · isoniazid resistance · Mycobacterium tuberculosis · second-line drugs · Extensively drug-resistant tuberculosis · Extensively drug-resistant tuberculosis · Drug susceptibility testing · treatment regimens · fluoroquinolones · injectable agents · bedaquiline · linezolid · Transmission dynamics · Treatment outcomes · Adverse events · directly observed therapy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Tuberculosis Research and Epidemiology Papers, Class of 2026. https://pri.pepkio.com/top-papers/tuberculosis-research-and-epidemiology/2026. Accessed 2026-07-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459